Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

被引：2
|
作者：
Kao, Jui-Hung [1 ]
Huang, Hsin-Tuan [1 ]
Li, Ko-Jen [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 08期
关键词：
CYCLOPHOSPHAMIDE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：780 / 781
页数：2
相关论文
共 50 条
  • [31] The natural history of progressive fibrosing interstitial lung diseases
    Brown, Kevin K.
    Martinez, Fernando J.
    Walsh, Simon L. F.
    Thannickal, Victor J.
    Prasse, Antje
    Schlenker-Herceg, Rozsa
    Goeldner, Rainer-Georg
    Clerisme-Beaty, Emmanuelle
    Tetzlaff, Kay
    Cottin, Vincent
    Wells, Athol U.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (06)
  • [32] Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
    Chen, Xianqiu
    Guo, Jian
    Yu, Dong
    Jie, Bing
    Zhou, Ying
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [33] The Burden of Progressive-Fibrosing Interstitial Lung Diseases
    Cottin, Vincent
    Teague, Rhiannon
    Nicholson, Lindsay
    Langham, Sue
    Baldwin, Mike
    FRONTIERS IN MEDICINE, 2022, 9
  • [34] NATIONAL UK EXPERIENCE OF THE TREATMENT OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE WITH NINTEDANIB
    Dixon, G.
    Hague, S.
    Thould, H.
    Khin, A. M. N.
    Mulholland, S.
    Gibbons, M.
    Barratt, S. L.
    THORAX, 2023, 78 (SUPPL_4) : A11 - A12
  • [35] Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
    Kreuter, M.
    Glazer, C.
    Kitamura, H.
    Koschel, D.
    Moua, T.
    Mueller, H.
    Stowasser, S.
    Rohr, K. B.
    Brown, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [36] Nintedanib for treating progressive fibrosing interstitial lung diseases (vol 9, pg e116, 2021)
    Adler, A. I.
    Guo, Y.
    Thiam, A.
    Elliott, N.
    Patel, S.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (01): : E9 - E9
  • [37] EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN PATIENTS WITH PROGRESSIVE FIBROSING AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES
    Maher, T.
    Bonella, F.
    Assassi, S.
    Noth, I.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K.
    Kolb, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 722 - 722
  • [38] Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
    Dixon, Giles
    Hague, Samuel
    Mulholland, Sarah
    Adamali, Huzaifa
    Khin, Aye Myat Noe
    Thould, Hannah
    Connon, Roisin
    Minnis, Paul
    Murtagh, Eoin
    Khan, Fasihul
    Toor, Sameen
    Lawrence, Alexandra
    Naqvi, Marium
    West, Alex
    Coker, Robina K.
    Ward, Katie
    Yazbeck, Leda
    Hart, Simon
    Garfoot, Theresa
    Newman, Kate
    Rivera-Ortega, Pilar
    Stranks, Lachlan
    Beirne, Paul
    Bradley, Jessica
    Rowan, Catherine
    Agnew, Sarah
    Ahmad, Mahin
    Spencer, Lisa G.
    Aigbirior, Joshua
    Fahim, Ahmed
    Wilson, Andrew M.
    Butcher, Elizabeth
    Chong, Sy Giin
    Saini, Gauri
    Zulfikar, Sabrina
    Chua, Felix
    George, Peter M.
    Kokosi, Maria
    Kouranos, Vasileios
    Molyneaux, Philip
    Renzoni, Elisabetta
    Vitri, Benedetta
    Wells, Athol U.
    Nicol, Lisa M.
    Bianchi, Stephen
    Kular, Raman
    Liu, Hua Jian
    John, Alexander
    Barth, Sarah
    Wickremasinghe, Melissa
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [39] Role of imaging in progressive-fibrosing interstitial lung diseases
    Walsh, Simon L. F.
    Devaraj, Anand
    Enghelmayer, Juan Ignacio
    Kishi, Kazuma
    Silva, Rafael S.
    Patel, Nina
    Rossman, Milton D.
    Valenzuela, Claudia
    Vancheri, Carlo
    EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150):
  • [40] Comment on "The natural history of progressive fibrosing interstitial lung diseases"
    Moodley, Yuben P.
    Zappala, Christopher
    Tedja, Chantalia
    Clynick, Britt
    Tan, Dino B. A.
    Walters, Eugene Haydn
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (06)
12345